{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:13:21Z","timestamp":1788812001388,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early detection of diabetic macular edema (DME) is essential to prevent vision loss through timely treatment. Optical coherence tomography (OCT) is the diagnostic gold standard but is not suitable for home monitoring. The Amsler grid represents a simple and inexpensive potential screening tool. This study aimed to determine the sensitivity of the Amsler grid for detecting DME and to assess its association with the size of foveal edema.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study, 1,444 eyes of 722 diabetic patients were examined using Spectralis OCT and the Amsler grid, and 90 eyes with DME were identified. A sensitivity analysis restricted to one eye per participant and excluding eyes with concomitant macular pathologies included 34 eyes with intrafoveal DME, in which the area of foveal edema was quantified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For very small DME (area\u2009\u2264\u20090.01\u00a0mm\u00b2), the sensitivity of the Amsler grid was 20.0% (1\/5 eyes). For edema areas\u2009&gt;\u20090.01\u00a0mm\u00b2, the sensitivity increased to 62.1% (18\/29 eyes), and for areas\u2009&gt;\u20090.03\u00a0mm\u00b2, it increased to 69.6% (16\/23 eyes).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The Amsler grid demonstrated limited sensitivity for detecting DME, particularly for small edema areas (\u2264\u20090.01\u00a0mm\u00b2). While it may serve as an adjunctive tool for home monitoring in diabetic patients, it cannot replace OCT-based examinations at recommended follow-up intervals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-026-05298-3","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T10:43:39Z","timestamp":1788605019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between macular edema area on optical coherence tomography and Amsler grid sensitivity in diabetic macular edema: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6671-9628","authenticated-orcid":false,"given":"Sophie","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"5298_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/5584_2020_535","volume":"1307","author":"A Gurreri","year":"2021","unstructured":"Gurreri A, Pazzaglia A. Diabetic Macular Edema: State of Art and Intraocular Pharmacological Approaches. Adv Exp Med Biol. 2021;1307:375\u201389. https:\/\/doi.org\/10.1007\/5584_2020_535.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"5298_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s2213-8587(25)00299-2","volume":"14","author":"I Genitsaridi","year":"2026","unstructured":"Genitsaridi I, Salpea P, Salim A, Sajjadi SF, Tomic D, James S, et al. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2026;14(2):149\u201356. https:\/\/doi.org\/10.1016\/s2213-8587(25)00299-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"5298_CR3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.survophthal.2022.01.009","volume":"67","author":"JHB Im","year":"2022","unstructured":"Im JHB, Jin YP, Chow R, Yan P. Prevalence of diabetic macular edema based on optical coherence tomography in people with diabetes: A systematic review and meta-analysis. Surv Ophthalmol. 2022;67(4):1244\u201351. https:\/\/doi.org\/10.1016\/j.survophthal.2022.01.009.","journal-title":"Surv Ophthalmol"},{"issue":"6 Suppl","key":"5298_CR4","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.37765\/ajmc.2023.89387","volume":"29","author":"A Almony","year":"2023","unstructured":"Almony A. Disease burden of neovascular age-related macular degeneration and diabetic macular edema. Am J Manag Care. 2023;29(6 Suppl):S75\u201380. https:\/\/doi.org\/10.37765\/ajmc.2023.89387.","journal-title":"Am J Manag Care"},{"issue":"9","key":"5298_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1055\/a-1545-9656","volume":"238","author":"T Barth","year":"2021","unstructured":"Barth T, Helbig H. [Diabetic Macular Edema]. Klin Monbl Augenheilkd. 2021;238(9):1029\u201343. https:\/\/doi.org\/10.1055\/a-1545-9656.","journal-title":"Klin Monbl Augenheilkd"},{"key":"5298_CR6","unstructured":"VersorgungsLeitlinie N. Pr\u00e4vention und Therapie von Netzhautkomplikationen bei Diabetes. Aufl; 2015."},{"key":"5298_CR7","unstructured":"Muqit M. ICO Guidelines For Diabetic Eye Care 2017. \u0412:(\u043d\u043e\u044f\u0431 2016). 2016."},{"issue":"7","key":"5298_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00347-016-0315-8","volume":"113","author":"F Ziemssen","year":"2016","unstructured":"Ziemssen F, Lemmen K, Bertram B, Hammes HP, Agostini H. [National guidelines for treatment of diabetic retinopathy: Second edition of the national guidelines for treatment of diabetic retinopathy]. Ophthalmologe. 2016;113(7):623\u201338. https:\/\/doi.org\/10.1007\/s00347-016-0315-8.","journal-title":"Ophthalmologe"},{"key":"5298_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/5584_2020_499","volume":"1307","author":"K Suriyasekeran","year":"2021","unstructured":"Suriyasekeran K, Santhanamahalingam S, Duraisamy M. Algorithms for Diagnosis of Diabetic Retinopathy and Diabetic Macula Edema- A Review. Adv Exp Med Biol. 2021;1307:357\u201373. https:\/\/doi.org\/10.1007\/5584_2020_499.","journal-title":"Adv Exp Med Biol"},{"key":"5298_CR10","doi-asserted-by":"publisher","first-page":"9036847","DOI":"10.1155\/2020\/9036847","volume":"2020","author":"R Galiero","year":"2020","unstructured":"Galiero R, Pafundi PC, Nevola R, Rinaldi L, Acierno C, Caturano A, et al. The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy. J Diabetes Res. 2020;2020:9036847. https:\/\/doi.org\/10.1155\/2020\/9036847.","journal-title":"J Diabetes Res"},{"key":"5298_CR11","doi-asserted-by":"publisher","unstructured":"Mohaghegh N, Ghafar-Zadeh E, Magierowski S. Recent advances of computerized graphical methods for the detection and progress assessment of visual distortion caused by macular disorders. Vision (Basel). 2019;3(2). https:\/\/doi.org\/10.3390\/vision3020025.","DOI":"10.3390\/vision3020025"},{"key":"5298_CR12","unstructured":"Tripathy K, Salini B. Amsler Grid. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020."},{"issue":"11","key":"5298_CR13","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1055\/a-1194-5211","volume":"237","author":"G Michelson","year":"2020","unstructured":"Michelson G, Forst T. Diabetic Macular Edema in Diabetological Practices. Klin Monbl Augenheilkd. 2020;237(11):1320\u20135. https:\/\/doi.org\/10.1055\/a-1194-5211.","journal-title":"Klin Monbl Augenheilkd"},{"issue":"12","key":"5298_CR14","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.4103\/ijo.IJO_1240_18","volume":"66","author":"DJ Browning","year":"2018","unstructured":"Browning DJ, Stewart MW, Lee C. Diabetic macular edema: Evidence-based management. Indian J Ophthalmol. 2018;66(12):1736\u201350. https:\/\/doi.org\/10.4103\/ijo.IJO_1240_18.","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"5298_CR15","doi-asserted-by":"publisher","first-page":"e027","DOI":"10.48130\/vns-0025-0027","volume":"42","author":"D Cao","year":"2025","unstructured":"Cao D, Yao J, Ting DSW, Tan GSW. Artificial intelligence in predicting anti-VEGF treatment response in diabetic macular edema: current progress and future directions. Vis Neurosci. 2025;42(1):e027. https:\/\/doi.org\/10.48130\/vns-0025-0027.","journal-title":"Vis Neurosci"},{"issue":"7","key":"5298_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/jamaophthalmol.2021.1275","volume":"139","author":"QS You","year":"2021","unstructured":"You QS, Tsuboi K, Guo Y, Wang J, Flaxel CJ, Bailey ST, et al. Comparison of Central Macular Fluid Volume With Central Subfield Thickness in Patients With Diabetic Macular Edema Using Optical Coherence Tomography Angiography. JAMA Ophthalmol. 2021;139(7):734\u201341. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.1275.","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"5298_CR17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1055\/s-0043-125080","volume":"236","author":"D Claessens","year":"2019","unstructured":"Claessens D, Schuster AK. [Correlation of Quantitative Metamorphopsia Measurement and Central Retinal Thickness in Diabetic Macular Edema and Age-Related Exsudative Macular Degeneration]. Klin Monbl Augenheilkd. 2019;236(7):877\u201384. https:\/\/doi.org\/10.1055\/s-0043-125080.","journal-title":"Klin Monbl Augenheilkd"},{"key":"5298_CR18","doi-asserted-by":"publisher","first-page":"3082560","DOI":"10.1155\/2018\/3082560","volume":"2018","author":"B Weingessel","year":"2018","unstructured":"Weingessel B, Mihaltz K, Gleiss A, Sulzbacher F, Schutze C, Vecsei-Marlovits PV. Treatment of Diabetic Macular Edema with Intravitreal Antivascular Endothelial Growth Factor and Prompt versus Deferred Focal Laser during Long-Term Follow-Up and Identification of Prognostic Retinal Markers. J Ophthalmol. 2018;2018:3082560. https:\/\/doi.org\/10.1155\/2018\/3082560.","journal-title":"J Ophthalmol"},{"issue":"3","key":"5298_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/08820538.2021.1889620","volume":"36","author":"MJ Tsai","year":"2021","unstructured":"Tsai MJ, Cheng CK. Intravitreal Aflibercept versus Ranibizumab for Diabetic Macular Edema in a Taiwanese Health Service Setting. Semin Ophthalmol. 2021;36(3):132\u20138. https:\/\/doi.org\/10.1080\/08820538.2021.1889620.","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"5298_CR20","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1038\/s41598-020-79288-w","volume":"11","author":"PJ Rodr\u00edguez-Vald\u00e9s","year":"2021","unstructured":"Rodr\u00edguez-Vald\u00e9s PJ, Rehak M, Zur D, Sala-Puigdollers A, Fraser-Bell S, Lupidi M, et al. GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME Study. Sci Rep. 2021;11(1):4738. https:\/\/doi.org\/10.1038\/s41598-020-79288-w.","journal-title":"Sci Rep"},{"key":"5298_CR21","doi-asserted-by":"publisher","first-page":"Cd008081","DOI":"10.1002\/14651858.CD008081.pub3","volume":"1","author":"G Virgili","year":"2015","unstructured":"Virgili G, Menchini F, Casazza G, Hogg R, Das RR, Wang X, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2015;1:Cd008081. https:\/\/doi.org\/10.1002\/14651858.CD008081.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"5298_CR22","doi-asserted-by":"publisher","unstructured":"Claessens D, Ichhpujani P, Singh RB. MacuFix\u00ae versus Amsler grid for metamorphopsia categorization for macular diseases. Int Ophthalmol. 2021;1\u201310. https:\/\/doi.org\/10.1007\/s10792-021-02017-3.","DOI":"10.1007\/s10792-021-02017-3"},{"key":"5298_CR23","doi-asserted-by":"publisher","DOI":"10.1055\/a-1809-5125","author":"D Claessens","year":"2022","unstructured":"Claessens D, Kr\u00fcger RV, Gr\u00f6tzinger L. Change in Sub-aspects of Vision-Related Quality of Life after Three Months of Using an App to Categorize Metamorphopsia. Klin Monbl Augenheilkd. 2022. https:\/\/doi.org\/10.1055\/a-1809-5125.","journal-title":"Klin Monbl Augenheilkd"},{"issue":"4","key":"5298_CR24","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/s0161-6420(99)00149-9","volume":"107","author":"JC Brown","year":"2000","unstructured":"Brown JC, Kylstra JA, Mah ML. Entoptic perimetry screening for central diabetic scotomas and macular edema. Ophthalmology. 2000;107(4):755\u20139. https:\/\/doi.org\/10.1016\/s0161-6420(99)00149-9.","journal-title":"Ophthalmology"},{"issue":"11","key":"5298_CR25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00347-006-1381-0","volume":"103","author":"C Klatt","year":"2006","unstructured":"Klatt C, Sendtner P, Ponomareva L, Hillenkamp J, Bunse A, Gabel VP, et al. [Diagnostics of metamorphopsia in retinal diseases of different origins]. Ophthalmologe. 2006;103(11):945\u201352. https:\/\/doi.org\/10.1007\/s00347-006-1381-0.","journal-title":"Ophthalmologe"},{"issue":"6","key":"5298_CR26","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archopht.1993.01090060064024","volume":"111","author":"RA Schuchard","year":"1993","unstructured":"Schuchard RA. Validity and interpretation of Amsler grid reports. Arch Ophthalmol. 1993;111(6):776\u201380. https:\/\/doi.org\/10.1001\/archopht.1993.01090060064024.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"5298_CR27","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/s0161-6420(03)00074-5","volume":"110","author":"A Loewenstein","year":"2003","unstructured":"Loewenstein A, Malach R, Goldstein M, Leibovitch I, Barak A, Baruch E, et al. Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthalmology. 2003;110(5):966\u201370. https:\/\/doi.org\/10.1016\/s0161-6420(03)00074-5.","journal-title":"Ophthalmology"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-05298-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05298-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05298-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:03:09Z","timestamp":1788811389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-05298-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5298"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-05298-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the ethics committee of the Universit\u00e4tsklinikum Erlangen. The procedures used in this study adhered to the tenets of the Declaration of Helsinki. Written informed consent to participate in the study was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present work was performed to fulfil the requirements for obtaining the degree of \u201cDr. med.\u201d.","order":2,"name":"Ethics","label":"Authors' information","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GM is the proprietor and manager of Talkingeyes & More GmbH, which developed the telemedical service Tele-Augenkonsil (Tele-Eye Consultation). SW declares no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"549"}}